Versant Venture Capital VI, L.P., 10% Owner at Monte Rosa Therapeutics, Inc. (GLUE), sold 1,320,057 shares at $9.66 ($2.8M) on 2024-10-28, disclosed to the SEC on 2024-10-30.
Open-market sale of $2.8M GLUE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,019,867 | $0 | 0.0% |
| 2 | $9.66 | 89,990 | $869K | 30.7% |
| 3 | $9.66 | 89,990 | $869K | 30.7% |
| 4 | $9.08 | 52,305 | $475K | 16.8% |
| 5 | $9.08 | 52,305 | $475K | 16.8% |
| 6 | $9.41 | 15,600 |
| $147K |
| 5.2% |
| Total | $2.15 avg | 1,320,057 | $2.8M | 100% |
| Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |
| OYST | SELL | 2021-10-20 | $16.3M | — | Filing → |